Teladoc Health, Inc.
NYSE:TDOC
8.09 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,602.415 | 2,406.84 | 2,032.707 | 1,093.962 | 553.307 | 417.907 | 233.279 | 123.157 | 77.384 | 43.528 | 19.906 |
| Cost of Revenue
| 760.031 | 743.987 | 650.258 | 390.829 | 184.465 | 128.735 | 61.623 | 31.971 | 21.041 | 9.929 | 4.186 |
| Gross Profit
| 1,842.384 | 1,662.853 | 1,382.449 | 703.133 | 368.842 | 289.172 | 171.656 | 91.186 | 56.343 | 33.599 | 15.72 |
| Gross Profit Ratio
| 0.708 | 0.691 | 0.68 | 0.643 | 0.667 | 0.692 | 0.736 | 0.74 | 0.728 | 0.772 | 0.79 |
| Reseach & Development Expenses
| 348.521 | 333.629 | 311.884 | 164.941 | 64.644 | 54.373 | 34.459 | 21.815 | 14.21 | 7.573 | 3.532 |
| General & Administrative Expenses
| 464.659 | 449.855 | 438.007 | 506.684 | 164.456 | 118.782 | 81.266 | 52.685 | 54.843 | 19.623 | 8.772 |
| Selling & Marketing Expenses
| 902.634 | 850.708 | 667.307 | 380.198 | 174.612 | 144.263 | 95.647 | 60.963 | 38.212 | 19.233 | 8.531 |
| SG&A
| 1,367.293 | 1,300.563 | 1,105.314 | 886.882 | 339.068 | 263.045 | 176.913 | 113.648 | 93.055 | 38.856 | 17.303 |
| Other Expenses
| 4.445 | 256.027 | 204.239 | 69.495 | 38.952 | 37.717 | 22.482 | 11.428 | 4.863 | 2.32 | 0.754 |
| Operating Expenses
| 2,052.885 | 1,890.219 | 1,621.437 | 1,121.318 | 442.664 | 355.135 | 233.854 | 146.891 | 112.128 | 48.749 | 21.589 |
| Operating Income
| -248.553 | 13,198.482 | -238.988 | -418.185 | -73.822 | -70.854 | -75.394 | -62.664 | -55.785 | -15.15 | -5.869 |
| Operating Income Ratio
| -0.096 | 5.484 | -0.118 | -0.382 | -0.133 | -0.17 | -0.323 | -0.509 | -0.721 | -0.348 | -0.295 |
| Total Other Income Expenses Net
| -33.607 | -26,861.825 | -145.668 | -157.808 | -35.633 | -4.891 | -27.318 | -15.413 | -2.199 | -1.499 | -0.056 |
| Income Before Tax
| -219.608 | -13,663.343 | -384.656 | -575.993 | -109.455 | -96.966 | -107.007 | -73.706 | -57.984 | -16.649 | -5.925 |
| Income Before Tax Ratio
| -0.084 | -5.677 | -0.189 | -0.527 | -0.198 | -0.232 | -0.459 | -0.598 | -0.749 | -0.382 | -0.298 |
| Income Tax Expense
| 0.76 | -3.812 | 44.137 | -90.857 | -10.591 | 0.118 | -0.225 | 0.51 | 0.036 | 0.388 | 0.094 |
| Net Income
| -220.368 | -13,659.531 | -428.793 | -485.136 | -98.864 | -97.084 | -106.782 | -74.216 | -58.02 | -17.037 | -6.019 |
| Net Income Ratio
| -0.085 | -5.675 | -0.211 | -0.443 | -0.179 | -0.232 | -0.458 | -0.603 | -0.75 | -0.391 | -0.302 |
| EPS
| -1.34 | -84.6 | -2.73 | -5.36 | -1.38 | -1.47 | -1.93 | -1.75 | -2.91 | -0.62 | -0.22 |
| EPS Diluted
| -1.34 | -84.6 | -2.73 | -5.36 | -1.38 | -1.47 | -1.93 | -1.75 | -2.91 | -0.62 | -0.22 |
| EBITDA
| 192.049 | 13,469.125 | -14.279 | -340.098 | -28.87 | -30.361 | -43.103 | -47.435 | -50.922 | -12.83 | -5.115 |
| EBITDA Ratio
| 0.074 | 5.596 | -0.007 | -0.311 | -0.052 | -0.073 | -0.185 | -0.385 | -0.658 | -0.295 | -0.257 |